As of 2025-05-23, the Fair Value of Apellis Pharmaceuticals Inc (APLS) is -8.90 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.78 USD, the upside of Apellis Pharmaceuticals Inc is -150.05%.
With the market price of 17.78 USD and our fair value calculation, Apellis Pharmaceuticals Inc (APLS) is not a good investment. Investing in Apellis stocks now will result in a potential loss of 150.05%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -344.90 | -746.40 | -652.20 | -528.63 | -197.88 | -494.00 |
| YoY growth | -13.19% | -116.41% | 12.62% | 18.95% | 62.57% | -7.09% |
| Market Cap (mil) | 2,234.59 |
| P/E | |
| Forward P/E |
| EPS | -1.78 |
| Avg earnings growth rate | -7.09% |
| TTM earnings | -223.68 |